9-2123639-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003070.5(SMARCA2):c.3763-80T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 1,244,436 control chromosomes in the GnomAD database, including 26,125 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.24 ( 6317 hom., cov: 32)
Exomes 𝑓: 0.16 ( 19808 hom. )
Consequence
SMARCA2
NM_003070.5 intron
NM_003070.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.831
Publications
5 publications found
Genes affected
SMARCA2 (HGNC:11098): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is highly similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, which contains a trinucleotide repeat (CAG) length polymorphism. [provided by RefSeq, Jan 2014]
SMARCA2 Gene-Disease associations (from GenCC):
- intellectual disability-sparse hair-brachydactyly syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 9-2123639-T-C is Benign according to our data. Variant chr9-2123639-T-C is described in ClinVar as Benign. ClinVar VariationId is 1259756.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.529 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMARCA2 | NM_003070.5 | c.3763-80T>C | intron_variant | Intron 26 of 33 | ENST00000349721.8 | NP_003061.3 | ||
| SMARCA2 | NM_001289396.2 | c.3763-80T>C | intron_variant | Intron 26 of 33 | NP_001276325.1 | |||
| SMARCA2 | NM_139045.4 | c.3763-80T>C | intron_variant | Intron 26 of 32 | NP_620614.2 | |||
| SMARCA2 | NM_001289397.2 | c.3589-80T>C | intron_variant | Intron 26 of 32 | NP_001276326.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.242 AC: 36771AN: 151816Hom.: 6293 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
36771
AN:
151816
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.157 AC: 171064AN: 1092502Hom.: 19808 AF XY: 0.158 AC XY: 87595AN XY: 555860 show subpopulations
GnomAD4 exome
AF:
AC:
171064
AN:
1092502
Hom.:
AF XY:
AC XY:
87595
AN XY:
555860
show subpopulations
African (AFR)
AF:
AC:
12445
AN:
26832
American (AMR)
AF:
AC:
9804
AN:
37972
Ashkenazi Jewish (ASJ)
AF:
AC:
2547
AN:
23354
East Asian (EAS)
AF:
AC:
21331
AN:
36784
South Asian (SAS)
AF:
AC:
17309
AN:
74746
European-Finnish (FIN)
AF:
AC:
8692
AN:
49782
Middle Eastern (MID)
AF:
AC:
916
AN:
5008
European-Non Finnish (NFE)
AF:
AC:
89758
AN:
789850
Other (OTH)
AF:
AC:
8262
AN:
48174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
6967
13935
20902
27870
34837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3174
6348
9522
12696
15870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.242 AC: 36842AN: 151934Hom.: 6317 Cov.: 32 AF XY: 0.247 AC XY: 18317AN XY: 74258 show subpopulations
GnomAD4 genome
AF:
AC:
36842
AN:
151934
Hom.:
Cov.:
32
AF XY:
AC XY:
18317
AN XY:
74258
show subpopulations
African (AFR)
AF:
AC:
18963
AN:
41406
American (AMR)
AF:
AC:
3024
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
368
AN:
3466
East Asian (EAS)
AF:
AC:
2814
AN:
5152
South Asian (SAS)
AF:
AC:
1197
AN:
4810
European-Finnish (FIN)
AF:
AC:
1763
AN:
10548
Middle Eastern (MID)
AF:
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8177
AN:
67960
Other (OTH)
AF:
AC:
445
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1244
2488
3733
4977
6221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1306
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.